Partner with us
Studies
/
Ketone monoester attenuates declines in cognitive performance and oxygen saturation during acute severe hypoxic exposure under resting conditions
Ketone ester/other
Human RCT
2024

Ketone monoester attenuates declines in cognitive performance and oxygen saturation during acute severe hypoxic exposure under resting conditions

Key finding
Ketone monoester attenuated the hypoxia-induced decline in cognitive performance, giving 6.8 more correct responses per minute than placebo (p = 0.018), alongside a smaller drop in oxygen saturation.
What the study did

In a single-blind randomized crossover study, 16 male military personnel performed cognitive tests at rest in room air, normoxia and hypoxia (6096 m, 9.7 percent O2, 20 minutes) after ketone monoester (650 mg/kg, split dose) or taste-matched placebo. Ketone monoester raised blood beta-hydroxybutyrate above 4 mM at 30 minutes and lowered blood glucose by about 20 mg/dL. The decline in cognitive efficiency during hypoxia was attenuated, with 6.8 more correct responses per minute than placebo (p = 0.018), and oxygen saturation was higher (76.8 vs 70.4 percent, p = 0.049).

This study used [form], not goBHB. It is shown here as general ketone science. Only goBHB studies back goBHB product claims.
GOBHB//QUERY_CONSOLE271 STUDIES INDEXED
> Ask what it does, which formats it goes into, or who is already using it.
What does BHB do?goBHB in gummies?Who is using goBHB?
Let me put a person on it

A goBHB specialist picks these up and answers inside one business day.

Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
Ask
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
Pharmaceutical grade, 48 patents, and over 300 million doses in market.
Ask me about goBHB